In light of the pandemic situation events until September 2021 are cancelled. We will inform customers directly when the events are rescheduled.    
COVID CANCELLED: Project Management in Human Resources,   Boston MA, Jan 6-8, 2021
COVID CANCELLED: InterDrone, The International Drone Conference,   Cambridge MA, Jan 11-13, 2021
COVID CANCELLED: Supplier Management for Medical Device Manufacturers,   Cambridge MA, Feb 2-4, 2021
COVID CANCELLED: US Immigration Compliance Strategies,   Boston MA, Feb 15-18, 2021
COVID CANCELLED: Project Management Training,   Boston MA, Mar 3-5, 2021
COVID CANCELLED: Internal Audit, Fraud Risk Assessment Workshop,   Boston MA, Mar 22-25, 2021
COVID CANCELLED: Agile / Scrum Training,   Boston MA, Apr 12-14, 2021
COVID CANCELLED: Validation, Verification and Transfer of Analytical Methods,   Boston MA, Apr 19-21, 2021
COVID CANCELLED: Computer System Validation - Reduce Costs and Avoid 483s,   Boston MA, May 10-12, 2021
COVID CANCELLED: SharePoint Technology Conference,   Boston MA, May 26-28, 2021
COVID CANCELLED: Employment Laws Certificate Program,   Boston MA, Jun 7-9, 2021
Following events are tentatively planned but may be rescheduled, based on CDC guidelines or attendee registration interest .    
TENTATIVE: 21 CFR Part 11 Compliance,   Boston MA, Sep 22-24, 2021
TENTATIVE: Quality Control Laboratory Compliance,   Boston MA, Oct 6-8, 2021
TENTATIVE: Analytical Instrument Qualification and System Validation,   Boston MA, Nov 15-17, 2021
TENTATIVE: FDA's New Import Program for 2021,   Boston MA, Dec 7-9, 2021

Boston Professional Events List

5th Macrophage-Directed Therapies Summit

Nov 13, 2023 - 08:30 AM - Nov 15, 05:00 PM
Hanson Wade
Wyndham Boston Beacon Hill
5, Blossom St

ZIP: 02114
Phone: +1 617 455 4188

Ticket Price: USD 2499.00 - USD 5696.00

Returning for the 5th year, the Macrophage-Directed Therapies Summit is your must-attend meeting to deep dive into biological cell plasticity and better understand how to reprogram and target macrophages within oncology, autoimmunity and inflammatory diseases.

Uniting experts across discovery, translation and clinical development, join this unique forum to benchmark relevant biomarkers for patient selection, scale-up engineered CAR-M, unlock optimal combinations and validate the next generation of therapies Gain competitor insights from those targeting CD47, SIRPα, VISTA, CD40, CD24 and more, to drive progression and safeguard established macrophage modulators.

Boasting clinical trial data, join industry leaders to gain translational lessons learned to assess the potential of macrophages as a monotherapy and through combination strategies, to guarantee clinical success of adoptive cell therapies, bispecifics and next-gen macrophage-directed therapies.

Tickets: https://go.evvnt.com/1868801-2?pid=1052
Brochure: https://go.evvnt.com/1868801-3?pid=1052

Drug Developer Pricing - Conference + Workshop Day: USD 4646.00,
Drug Developer Pricing - Conference Only: USD 2899.00,
Academic Pricing - Conference + Workshop Day: USD 3996.00,
Academic Pricing - Conference Only: USD 2499.00,
Vendor Pricing - Conference + Workshop Day: USD 5696.00,
Vendor Pricing - Conference Only: USD 3599.00

Speaker Details

Abe Maingi, Co-Founder and Vice President, Business Development, Inceptor Bio, Andrew Pincetic, Director, Immuno-Neurology, Alector, Daniela Schloesser, Senior Scientist, Boehringer Ingelheim, David Ralph, Senior Director, Drug Discovery, Navidea Biopharmaceuticals, David Rodgers, Senior Director, Macrophage Cell Therapy, Shoreline Biosciences, David Young, Chief Executive Officer, KisoJi Biotechnology Inc., Debashis Sahoo, Associate Professor, University of California School of Medicine, George Fromm, Chief Scientific Officer, Shattuck Labs, Jennifer Guerriero, Assistant Professor, Harvard Medical School, Judith Varner, Professor, Pathology, UC San Diego, Karim Christian El Kasmi, Senior Associate Director, Boehringer Ingelheim, Kipp Weiskopf, Valhalla Whitehead Fellow, Whitehead Institute, Michael Brehm, Associate Professor, Molecular Medicine, UMass Chan Medical School, Michael Klichinsky, Co-Founder and Chief Scientific Officer, Carisma Therapeutics, Michael McGrath, Professor Emeritus of Medicine, UCSF, Nathanael McCurley, Co-Founder and Vice President, Research and Development, SIRPant ImmunoTherapeutics, Roy Noy, Senior Staff Scientist, Regeneron Pharmaceuticals, Stephen Myatt, Chief Executive Officer, Macomics, Stuart Hughes, Chief Executive Officer, Pathios Therapeutics, Sumiti Jain Vice President, Research and Development, Inceptor Bio, Tatiana Novobrantseva, Chief Scientific Officer, Immunology, Moderna, Thierry Guillaudeux, Chief Scientific Officer, Kineta Inc., Thomas Marron, Director, Early Phase Trials Unit, Associate Professor of Medicine and Immunology, Icahn School of Medicine at Mount Sinai, Tomasz Rygiel, Co-founder and Chief Scientific Officer, Cellis, Zdravka Medarova, Chief Technology Officer, TransCode Therapeutics

Event Categories
Keywords: conference , science


Events Calendar

29 30 31 1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 1 2

Event Location


VIP Life Time Subscription to our Newsletters!